Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity
Article in Journal of International Medical Research (February 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
Article in Therapeutics and Clinical Risk Management (July 2020)
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database
Article in International Journal of MS Care (May 2017)